DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Clioquinol is an investigational drug.
There have been 3 clinical trials for Clioquinol. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Leukemia, Lymphoid, Myelodysplastic Syndromes, and Leukemia, Lymphocytic, Chronic, B-Cell. The leading clinical trial sponsors are EMS, University Health Network, Toronto, and University Hospital, Lille.
Recent Clinical Trials for Clioquinol
|Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous||EMS||Phase 3|
|Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease||University Hospital, Lille||Phase 2/Phase 3|
|Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy||University Health Network, Toronto||Phase 1|